Treated apatite particles for x-ray diagnostic imaging

Treated apatite particles are disclosed for enhancing medical diagnostic imaging such as magnetic resonance imaging ("MRI"), magnetic resonance spectroscopy ("MRS"), magnetic resonance spectroscopy imaging (37 MRSI"), X-ray diagnostic imaging, and ultrasound imaging. Novel c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DEUTSCH, KAREN F, WOULFE, STEVEN R, NOSCO, DENNIS L, RALSTON, WILLIAM H, MEEH, LINDA, EDWARD A, WHITE, DAVID H, WILKING, JANET B, WOLFANGEL, ROBERT G, CACHERIS, WILLIAM P
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DEUTSCH
KAREN F
WOULFE
STEVEN R
NOSCO
DENNIS L
RALSTON
WILLIAM H
MEEH
LINDA
DEUTSCH
EDWARD A
WHITE
DAVID H
WILKING
JANET B
WOLFANGEL
ROBERT G
CACHERIS
WILLIAM P
description Treated apatite particles are disclosed for enhancing medical diagnostic imaging such as magnetic resonance imaging ("MRI"), magnetic resonance spectroscopy ("MRS"), magnetic resonance spectroscopy imaging (37 MRSI"), X-ray diagnostic imaging, and ultrasound imaging. Novel coating and manufacturing techniques are disclosed to control particle size and particle aggregation resulting in compositions for organ specific imaging of the liver, spleen, gastrointestinal tract, or tissue disease states is obtained. Depending on the diagnostic imaging technique, apatite particles are treated to be paramagnetic, radiopaque, or echogenic. The apatite particles may also be fluorinated to form stable fluoroapatite compositions useful for 19F imaging. Also disclosed are diagnostic compositions and methods of performing medical diagnostic procedures which involve administering to a warm-blooded animal a diagnostically effective amount of the abovedescribed apatite particles and then performing the medical diagnostic procedure.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US5468465A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US5468465A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US5468465A3</originalsourceid><addsrcrecordid>eNrjZDALKUpNLElNUUgsSCzJLElVKEgsKslMzkktVkjLL1Ko0C1KrFRIyUxMz8svBoorZOYmpmfmpfMwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUkvjQYFMTMwsTM1NHY8IqAPZkLQQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Treated apatite particles for x-ray diagnostic imaging</title><source>esp@cenet</source><creator>DEUTSCH; KAREN F ; WOULFE; STEVEN R ; NOSCO; DENNIS L ; RALSTON; WILLIAM H ; MEEH; LINDA ; DEUTSCH; EDWARD A ; WHITE; DAVID H ; WILKING; JANET B ; WOLFANGEL; ROBERT G ; CACHERIS; WILLIAM P</creator><creatorcontrib>DEUTSCH; KAREN F ; WOULFE; STEVEN R ; NOSCO; DENNIS L ; RALSTON; WILLIAM H ; MEEH; LINDA ; DEUTSCH; EDWARD A ; WHITE; DAVID H ; WILKING; JANET B ; WOLFANGEL; ROBERT G ; CACHERIS; WILLIAM P</creatorcontrib><description>Treated apatite particles are disclosed for enhancing medical diagnostic imaging such as magnetic resonance imaging ("MRI"), magnetic resonance spectroscopy ("MRS"), magnetic resonance spectroscopy imaging (37 MRSI"), X-ray diagnostic imaging, and ultrasound imaging. Novel coating and manufacturing techniques are disclosed to control particle size and particle aggregation resulting in compositions for organ specific imaging of the liver, spleen, gastrointestinal tract, or tissue disease states is obtained. Depending on the diagnostic imaging technique, apatite particles are treated to be paramagnetic, radiopaque, or echogenic. The apatite particles may also be fluorinated to form stable fluoroapatite compositions useful for 19F imaging. Also disclosed are diagnostic compositions and methods of performing medical diagnostic procedures which involve administering to a warm-blooded animal a diagnostically effective amount of the abovedescribed apatite particles and then performing the medical diagnostic procedure.</description><edition>6</edition><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F ; COMPOUNDS THEREOF ; DIAGNOSIS ; HUMAN NECESSITIES ; HYGIENE ; IDENTIFICATION ; INORGANIC CHEMISTRY ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NON-METALLIC ELEMENTS ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SURGERY</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19951121&amp;DB=EPODOC&amp;CC=US&amp;NR=5468465A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19951121&amp;DB=EPODOC&amp;CC=US&amp;NR=5468465A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DEUTSCH; KAREN F</creatorcontrib><creatorcontrib>WOULFE; STEVEN R</creatorcontrib><creatorcontrib>NOSCO; DENNIS L</creatorcontrib><creatorcontrib>RALSTON; WILLIAM H</creatorcontrib><creatorcontrib>MEEH; LINDA</creatorcontrib><creatorcontrib>DEUTSCH; EDWARD A</creatorcontrib><creatorcontrib>WHITE; DAVID H</creatorcontrib><creatorcontrib>WILKING; JANET B</creatorcontrib><creatorcontrib>WOLFANGEL; ROBERT G</creatorcontrib><creatorcontrib>CACHERIS; WILLIAM P</creatorcontrib><title>Treated apatite particles for x-ray diagnostic imaging</title><description>Treated apatite particles are disclosed for enhancing medical diagnostic imaging such as magnetic resonance imaging ("MRI"), magnetic resonance spectroscopy ("MRS"), magnetic resonance spectroscopy imaging (37 MRSI"), X-ray diagnostic imaging, and ultrasound imaging. Novel coating and manufacturing techniques are disclosed to control particle size and particle aggregation resulting in compositions for organ specific imaging of the liver, spleen, gastrointestinal tract, or tissue disease states is obtained. Depending on the diagnostic imaging technique, apatite particles are treated to be paramagnetic, radiopaque, or echogenic. The apatite particles may also be fluorinated to form stable fluoroapatite compositions useful for 19F imaging. Also disclosed are diagnostic compositions and methods of performing medical diagnostic procedures which involve administering to a warm-blooded animal a diagnostically effective amount of the abovedescribed apatite particles and then performing the medical diagnostic procedure.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F</subject><subject>COMPOUNDS THEREOF</subject><subject>DIAGNOSIS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>IDENTIFICATION</subject><subject>INORGANIC CHEMISTRY</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NON-METALLIC ELEMENTS</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SURGERY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDALKUpNLElNUUgsSCzJLElVKEgsKslMzkktVkjLL1Ko0C1KrFRIyUxMz8svBoorZOYmpmfmpfMwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUkvjQYFMTMwsTM1NHY8IqAPZkLQQ</recordid><startdate>19951121</startdate><enddate>19951121</enddate><creator>DEUTSCH; KAREN F</creator><creator>WOULFE; STEVEN R</creator><creator>NOSCO; DENNIS L</creator><creator>RALSTON; WILLIAM H</creator><creator>MEEH; LINDA</creator><creator>DEUTSCH; EDWARD A</creator><creator>WHITE; DAVID H</creator><creator>WILKING; JANET B</creator><creator>WOLFANGEL; ROBERT G</creator><creator>CACHERIS; WILLIAM P</creator><scope>EVB</scope></search><sort><creationdate>19951121</creationdate><title>Treated apatite particles for x-ray diagnostic imaging</title><author>DEUTSCH; KAREN F ; WOULFE; STEVEN R ; NOSCO; DENNIS L ; RALSTON; WILLIAM H ; MEEH; LINDA ; DEUTSCH; EDWARD A ; WHITE; DAVID H ; WILKING; JANET B ; WOLFANGEL; ROBERT G ; CACHERIS; WILLIAM P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US5468465A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1995</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F</topic><topic>COMPOUNDS THEREOF</topic><topic>DIAGNOSIS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>IDENTIFICATION</topic><topic>INORGANIC CHEMISTRY</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NON-METALLIC ELEMENTS</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SURGERY</topic><toplevel>online_resources</toplevel><creatorcontrib>DEUTSCH; KAREN F</creatorcontrib><creatorcontrib>WOULFE; STEVEN R</creatorcontrib><creatorcontrib>NOSCO; DENNIS L</creatorcontrib><creatorcontrib>RALSTON; WILLIAM H</creatorcontrib><creatorcontrib>MEEH; LINDA</creatorcontrib><creatorcontrib>DEUTSCH; EDWARD A</creatorcontrib><creatorcontrib>WHITE; DAVID H</creatorcontrib><creatorcontrib>WILKING; JANET B</creatorcontrib><creatorcontrib>WOLFANGEL; ROBERT G</creatorcontrib><creatorcontrib>CACHERIS; WILLIAM P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DEUTSCH; KAREN F</au><au>WOULFE; STEVEN R</au><au>NOSCO; DENNIS L</au><au>RALSTON; WILLIAM H</au><au>MEEH; LINDA</au><au>DEUTSCH; EDWARD A</au><au>WHITE; DAVID H</au><au>WILKING; JANET B</au><au>WOLFANGEL; ROBERT G</au><au>CACHERIS; WILLIAM P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Treated apatite particles for x-ray diagnostic imaging</title><date>1995-11-21</date><risdate>1995</risdate><abstract>Treated apatite particles are disclosed for enhancing medical diagnostic imaging such as magnetic resonance imaging ("MRI"), magnetic resonance spectroscopy ("MRS"), magnetic resonance spectroscopy imaging (37 MRSI"), X-ray diagnostic imaging, and ultrasound imaging. Novel coating and manufacturing techniques are disclosed to control particle size and particle aggregation resulting in compositions for organ specific imaging of the liver, spleen, gastrointestinal tract, or tissue disease states is obtained. Depending on the diagnostic imaging technique, apatite particles are treated to be paramagnetic, radiopaque, or echogenic. The apatite particles may also be fluorinated to form stable fluoroapatite compositions useful for 19F imaging. Also disclosed are diagnostic compositions and methods of performing medical diagnostic procedures which involve administering to a warm-blooded animal a diagnostically effective amount of the abovedescribed apatite particles and then performing the medical diagnostic procedure.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US5468465A
source esp@cenet
subjects ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F
COMPOUNDS THEREOF
DIAGNOSIS
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
INORGANIC CHEMISTRY
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NON-METALLIC ELEMENTS
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SURGERY
title Treated apatite particles for x-ray diagnostic imaging
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T00%3A26%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DEUTSCH;%20KAREN%20F&rft.date=1995-11-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS5468465A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true